CytoDyn (CYDY) Current Assets (2011 - 2026)

CytoDyn's Current Assets history runs 16 years deep, the most recent figure standing at $18.4 million for Q1 2026.

• Quarterly Current Assets fell 12.13% year-over-year to $18.4 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $18.4 million (down 12.13% YoY) and the FY2025 annual result came in at $17.9 million, up 65.31% from the prior year.
• Current Assets was $18.4 million for Q1 2026 at CytoDyn, up from $8.8 million in the prior quarter.
• Across five years, Current Assets topped out at $92.3 million in Q1 2022 and bottomed at $6.6 million in Q4 2022.
• A 5-year average of $18.7 million and a median of $12.0 million in 2023 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2022 — Current Assets plunged 93.57% — and 2024, when it soared 178.65%.
• CytoDyn's Current Assets stood at $6.6 million in 2022, then soared by 34.94% to $8.8 million in 2023, then surged by 178.65% to $24.6 million in 2024, then tumbled by 64.12% to $8.8 million in 2025, then jumped by 108.6% to $18.4 million in 2026.
• Business Quant data shows CYDY's Current Assets at $18.4 million in Q1 2026, $8.8 million in Q4 2025, and $13.4 million in Q3 2025.